| Element List | Explanation |
|---|---|
| Introduction | Basma Adeem Medical Company announces to its shareholders the results of the Extraordinary General Assembly Meeting (First Meeting), which was held at 7:20 PM on Thursday, 10/01/1448 AH, corresponding to 25/06/2026 AD, at the company's headquarters located in Riyadh - King Abdulaziz Road - Al Yasmin District, via modern technology (remotely) using Tadawulaty services, after the legal quorum for the validity of the meeting was met. |
| City and Location of the General Assembly's Meeting | The company's main headquarters is located in Riyadh - King Abdulaziz Road - Al-Yasmin District, through modern technology (remotely) - using Tadawulati services. |
| Date of the General Assembly's Meeting | 2026-06-25 Corresponding to 1448-01-10 |
| Time of the General Assembly’s Meeting | 19:20 |
| Percentage of Attending Shareholders | 53.77% |
| Names of the Board of Directors' Members Present at the General Assembly's Meeting and Names of the Absentees | 1- Omar Sulaiman Al Ajaji - Chairman of the Board of Directors 2- Osama Abdulrahman Al Shaalan - Vice Chairman of the Board of Directors 3- Mohammed Abdul Aziz Saad Al Bawardi - Managing Director and Chief Executive Officer 4- Azzam bin Omar bin Abdulrahman Al Mufdi - Board Member 5- Ahmed Saleh Al Washil - Board Member |
| Names of the Chairmen of the Committees Present at the General Assembly's Meeting or Members of such Committees Attending on Their Behalf | 1. Musab Khalid Al-Hadlaq - Chairman of the Audit Committee 2. Abdulaziz Mohammed Al-Awshan - Member of the Audit Committee 3. Meshal Saad Al-Jabali - Member of the Audit Committee |
| Voting Results on the Items of the General Assembly's Meeting Agenda's | 1. The Board of Directors' report for the fiscal year ending December 31, 2025, was reviewed and discussed. 2. The financial statements for the fiscal year ending December 31, 2025, were reviewed and discussed. 3. The company's auditor's report for the fiscal year ending December 31, 2025, was approved after discussion. 4. The Board of Directors was discharged from liability for the fiscal year ending December 31, 2025. 5. The appointment of RSM United Accountants Professional Consulting, from among the nominees, was approved to examine, review, and audit the interim semi-annual and annual financial statements for the fiscal year ending December 31, 2026, for a total fee of two hundred and fifteen thousand Saudi Riyals (SAR 215,000). 6. Approval of the disbursement of SAR 430,000 as a bonus and attendance allowance for the Board of Directors for the fiscal year ending December 31, 2025. 7. Approval of the company's employee name program and authorization for the Board of Directors to determine the program's terms and conditions in accordance with applicable regulations and bylaws. 8. Approval to authorize the Board of Directors with the authority of the Ordinary General Assembly to authorize the license mentioned in paragraph (1) of Article Twenty-Seven of the Companies Law, for a period of one year from the date of approval of the General Assembly or until the end of the term of the authorized Board of Directors, whichever is earlier, in accordance with the conditions mentioned in the Executive Regulations of the Companies Law for listed joint-stock companies. |
Basma Adeem Medical Co. Announces the Results of the Extraordinary General Assembly Meeting (First Meeting)
AI Summary
- Shareholders approved the FY 2025 financial statements and auditor’s report, while discharging the Board of Directors from liability for the same period.
- RSM United Accountants was appointed to audit the semi-annual and annual financial statements for FY 2026 for a total fee of SAR 215,000.
- The assembly approved the disbursement of SAR 430,000 in bonuses and attendance allowances for the Board of Directors for the 2025 fiscal year.
- Shareholders approved an employee incentive program and authorized the Board to exercise certain General Assembly powers regarding Article 27 licensing for a one-year period.
